Literature DB >> 16713902

Informatics solutions for high-throughput proteomics.

Thodoros Topaloglou1.   

Abstract

The success of mass-spectrometry-based proteomics as a method for analyzing proteins in biological samples is accompanied by challenges owning to demands for increased throughput. These challenges arise from the vast volume of data generated by proteomics experiments combined with the heterogeneity in data formats, processing methods, software tools and databases that are involved in the translation of spectral data into relevant and actionable information for scientists. Informatics aims to provide answers to these challenges by transferring existing solutions from information management to proteomics and/or by generating novel computational methods for automation of proteomics data processing.

Mesh:

Substances:

Year:  2006        PMID: 16713902     DOI: 10.1016/j.drudis.2006.04.011

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  4 in total

1.  HTAPP: high-throughput autonomous proteomic pipeline.

Authors:  Kebing Yu; Arthur R Salomon
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

2.  Factors that contribute to the misidentification of tyrosine nitration by shotgun proteomics.

Authors:  Stanley M Stevens; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Mol Cell Proteomics       Date:  2008-08-16       Impact factor: 5.911

3.  PeptideDepot: flexible relational database for visual analysis of quantitative proteomic data and integration of existing protein information.

Authors:  Kebing Yu; Arthur R Salomon
Journal:  Proteomics       Date:  2009-12       Impact factor: 3.984

4.  A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface.

Authors:  Xiaoxiao Li; James LeBlanc; Allison Truong; Ravi Vuthoori; Sharon S Chen; Jonathan L Lustgarten; Bennett Roth; Jeff Allard; Andrew Ippoliti; Laura L Presley; James Borneman; William L Bigbee; Vanathi Gopalakrishnan; Thomas G Graeber; David Elashoff; Jonathan Braun; Lee Goodglick
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.